Overview

RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease

Status:
Unknown status
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate an antibiotic therapy called Rifalazil to determine its effect on hardening of the carotid arteries.
Phase:
Phase 2
Details
Lead Sponsor:
ActivBiotics
Treatments:
KRM 1648
Rifamycins